Florida Best Practice Medication Guidelines Survey Results
One of the main goals of the Florida Medicaid Drug Therapy Management Program (MDTMP) is to improve the quality of psychotherapeutic drug prescribing practices based on the strength of the current scientific information. Evidence based guidelines were developed by the Program for children, adolescents and adults utilizing national and Florida experts and extensive reviews of the behavioral health literature. From time to time we survey the users of the Florida psychotherapeutic guidelines to better understand how the guidelines are used and make improvements based on responses. Recently a survey was administered in order to gather general information in regards to the use of the Florida Best Practice Medication Guidelines and other prescribing practices. This survey was sent to over 400 clinicians via hard mail and e-mail, resulting in an approximate 15% response rate. A summary of the current results include:
- 88% reported using some type of clinical guidelines for their decisions of care.
- 71% reported familiarity with the Florida Best Practice Medication Guidelines
- 69% reported utilizing the Florida Best Practice Medication Guidelines
- 53% reported not using the guidelines due to unfamiliarity
- The majority of respondents stated that personal experience, clinical guidelines and discussion with peers, respectively, were factors that affected their decision when determining a course of therapy.
- Evidence-based medicine was considered to be a strong or very strong influence on clinical decision-making, whereas changes in reimbursement practices had mostly some or no influence on decisions.
- 89% of respondents expressed interest in receiving the Florida Best Practice Medication Guidelines
The preferred methods of receiving the guidelines were via hard copy, online and smart phone application respectively.
- Online and hard copy were almost equally favored
For the highest-quality video, please view videos in the latest browser available.
If you have any questions or issues, please contact